Cadila Healthcare has informed that it enclosed a copy of press release dated November 23, 2021, titled ‘Zydus develops new treatment for patients suffering from Chronic Kidney Disease (CKD), submits first New Drug Application (NDA) to DCGI’.
The above information is a part of company’s filings submitted to BSE.